CCM
BMY icon

Crossvault Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Crossvault Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-119,591
Closed -$6.22M – 79
2018
Q4 		$6.22M Sell
119,591
-1,001
-0.8% -$53.8K 3.53% 10
2018
Q3 		$7.49M Sell
120,592
-6,529
-5% -$387K 3.86% 8
2018
Q2 		$7.04M Sell
127,121
-1,550
-1% -$83.7K 3.75% 7
2018
Q1 		$8.14M Buy
128,671
+350
+0.3% +$22.5K 4.63% 4
2017
Q4 		$7.86M Sell
128,321
-225
-0.2% -$14.1K 4.15% 5
2017
Q3 		$8.19M Buy
128,546
+6,057
+5% +$354K 4.7% 4
2017
Q2 		$6.83M Buy
122,489
+275
+0.2% +$15K 4.1% 4
2017
Q1 		$6.65M Buy
122,214
+105
+0.1% +$5.76K 4.13% 3
2016
Q4 		$7.14M Buy
122,109
+6,535
+6% +$357K 4.81% 2
2016
Q3 		$6.23M Buy
115,574
+3,672
+3% +$236K 4.34% 3
2016
Q2 		$8.23M Sell
111,902
-25
-0% -$1.77K 5.82% 1
2016
Q1 		$7.15M Sell
111,927
-4,040
-3% -$255K 5.27% 1
2015
Q4 		$7.98M Sell
115,967
-675
-0.6% -$44.6K 5.67% 1
2015
Q3 		$6.91M Buy
116,642
+7,634
+7% +$484K 5.4% 1
2015
Q2 		$7.25M Buy
109,008
+1,375
+1% +$90.6K 5.8% 1
2015
Q1 		$6.94M Buy
107,633
+985
+0.9% +$61.7K 5.55% 1
2014
Q4 		$6.29M Sell
106,648
-705
-0.7% -$39.8K 5.51% 1
2014
Q3 		$5.49M Buy
107,353
+1,340
+1% +$66.9K 5.19% 1
2014
Q2 		$5.14M Sell
106,013
-1,375
-1% -$67.8K 4.79% 1
2014
Q1 		$5.58M Buy
107,388
+2,800
+3% +$149K 5.41% 1
2013
Q4 		$5.56M Buy
+104,588
New +$5.33M 5.37% 1

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Crossvault Capital Management's BMY Position: Q1 2019 in Review

Crossvault Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 119,591 shares — an estimated $6.22M sold.

Crossvault Capital Management first reported a position in BMY in Q4 2013 and held it in 21 quarters. The position peaked at $8.23M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Crossvault Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Crossvault Capital Management sold 119,591 Bristol-Myers Squibb shares in Q1 2019, an estimated $6.22M.
  • Crossvault Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 21 quarters.
  • Crossvault Capital Management's Bristol-Myers Squibb position peaked at $8.23M in Q2 2016.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Crossvault Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.